Freenome

What is Freenome?

Freenome is a biotechnology company developing blood-based tests to detect cancer at its earliest, most treatable stages. Its approach is "multiomics": from a routine blood draw, it measures many different biological signals at once and uses artificial intelligence to find the patterns that indicate cancer, with the goal of making powerful screening as easy and accessible as a standard blood test. Its lead product is SimpleScreen CRC, a blood test for colorectal cancer screening, which has been moving through clinical validation and US FDA review; Freenome has also formed commercialization partnerships (for example licensing to Exact Sciences and working with Abbott to commercialize in the US) and has collaborated with Roche to help take blood-based screening worldwide. Freenome was founded in 2014 and is headquartered in Brisbane, California, in the South San Francisco Bay Area, and employs roughly 400 people. It is led by CEO Aaron Elliott, Ph.D., who previously led REALM IDx (parent of Ambry Genetics). Freenome raised more than $1.3 billion as a private company, and in July 2026 it debuted as a publicly traded company through a SPAC merger, entering the roughly $18 billion early-cancer-detection market alongside other players.

Mission & values

Outpace cancer through early detection, making powerful cancer screening as accessible as a routine blood test.

Qualifications

Freenome's roles split across the disciplines a diagnostics biotech needs, and where they sit matters for remote seekers. The lab and clinical side, wet-lab scientists, assay and R&D scientists, lab operations and technicians, clinical operations, regulatory affairs, and quality, is largely on-site, because the work happens in labs and clinical settings in the Bay Area. The data, technology, and corporate side is more remote or hybrid friendly: data science, machine learning and computational biology (central to its multiomics approach), software and data engineering, bioinformatics, product, plus commercial, market access, finance, legal, and people functions. Application flow lives at freenome.com/careers. As a US-based, now-public company, roles generally require US work authorization, and each posting specifies whether it is on-site, hybrid, or remote. Advanced degrees are common for scientific and computational roles, and experience in diagnostics, genomics, oncology, or machine learning on biological data is a strong signal. Check each posting for location and remote eligibility.

Leadership

Hiring process

1. 1

   Apply at freenome.com careers

   Browse lab/clinical, R&D and assay science, data science/ML and bioinformatics, software/data engineering, product, and commercial/corporate roles and submit through the Freenome careers site. Postings state on-site vs hybrid/remote.

2. 2

   Recruiter screen

   Confirms role fit, level, US work authorization, on-site vs hybrid/remote expectations, and pay.

   About 7 days

3. 3

   Technical or scientific interview

   Science/lab: domain and methods discussion. Data/ML/bioinformatics: modeling and a research or take-home exercise. Engineering: coding and system design. Commercial: a case.

   About 10 days

4. 4

   Panel interviews

   Cross-functional interviews with scientists, engineers, and stakeholders on depth and fit.

   About 10 days

5. 5

   Offer

   Offer with base plus equity as a public company, aligned to role and location.

   About 7 days

Funding

Awards & recognition

• Debuted as a publicly traded company via SPAC merger · 2026

  Freenome

• Advanced its SimpleScreen CRC blood test for colorectal cancer through FDA review · 2026

  Freenome

Company information

• Industry: Biotech / Early Cancer Detection
• Location: Brisbane, CA, USA (lab/clinical on-site; corporate/tech some remote)
• Founded: 2014
• Employees: 400
• Website: www.freenome.com ↗
• LinkedIn: Company page ↗

Frequently asked questions